Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions

Medical Care

Volumn 45, Issue 5, 2007, Pages 456-462

  Malone, Daniel C ^a   Abarca, Jacob ^b   Skrepnek, Grant H ^a   Murphy, John E ^a   Armstrong, Edward P ^a   Grizzle, Amy J ^a   Rehfeld, Rick A ^a   Woosley, Raymond L ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b Wellpoint NextRx   (United States)

^c CRITICAL PATH INSTITUTE   (United States)

Author keywords

Drug drug interactions; Medical errors; Medication safety; Pharmacist; Workload

Indexed keywords

ARTICLE; DRUG INTERACTION; EPIDEMIOLOGY; HEALTH INSURANCE; HUMAN; INSURANCE; MEDICAL INFORMATION SYSTEM; MEDICATION ERROR; PERSONNEL MANAGEMENT; PHARMACIST; PHARMACY; RISK; SAFETY; STANDARD; STATISTICS; UNITED STATES; UTILIZATION REVIEW; WORKLOAD;

CLINICAL PHARMACY INFORMATION SYSTEMS; DRUG INTERACTIONS; HEALTH CARE SURVEYS; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, PHARMACEUTICAL SERVICES; MEDICATION ERRORS; PERSONNEL STAFFING AND SCHEDULING; PHARMACIES; PHARMACISTS; RISK; SAFETY MANAGEMENT; UNITED STATES; WORKLOAD;

EID: 34247373137     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000257839.83765.07     Document Type: Article

References (49)

1. Kohn LTCJ, Donaldson MS. To Err is Human: Building a Safer Health Care System. Washington, DC: National Academy Press, Institute of Medicine Committee on Quality in Health Care in America; 2000.
2. Committee on Quality Health Care in America IoM. Crossing the Quality Chasm: A New Health System for 21st Century. Washington, DC: National Academy Press; 2001.
3. Committee on Data Standards for Patient Safety IoM. Key Capabilities of an Electronic Health Record System: Letter Report. 2003:35.
4. Aspden PCJ, Wolcott J, Erickson SM, eds. Patient Safety: Achieving a New Standard for Care. Washington, DC: National Academy Press, Institute of Medicine Committee on Data Standards for Patient Safety; 2004.
5. Chui MA, Rupp MT. Evaluation of online prospective DUR programs in community pharmacy practice. J Manag Care Pharm. 2000;6:27-32.
6. Murphy JE, Forrey RA, Desiraju U. Community pharmacists' responses to drug-drug interaction alerts. Am J Health Syst Pharm. 2004;61:1484-1487.
7. Knapp KK, Quist RM, Walton SM, et al. Update on the pharmacist shortage: national and state data through 2003. Am J Health Syst Pharm. 2005;62:492-499.
8. Martin EW. Drug Interaction Index. Philadelphia, PA: J.B. Lippincott Company; 1978.
9. Abarca J, Malone DC, Skrepnek GH, et al. Community pharmacy managers' perceptions of computerized drag-drug interaction alerts. J Am Pharm Assoc. 2006;46:148-153.
10. Skrepnek GH, Armstrong EP, Malone DC, et al. Workload and availability of technology in metropolitan community pharmacies. J Am Pharm Assoc. 2006;46:154-160.
11. Malone DC, Abarca J, Hansten PD, et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions [see comment]. J Am Pharm Assoc. 2004;44:142-151.
12. Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drag interaction compendia [see comment], J Am Pharm Assoc. 2004;44:136-141.
13. Sellers JA. Too many medication errors, not enough pharmacists. Am J Health Syst Pharm. 2000;57:337.
14. NACDS. Retail prescription drag market-number of prescriptions. 2005. Available at: http://www.nacds.org/user-assets/pdfs/facts_resources/2005/ Prescriptions2005.pdf. Accessed March 14, 2006.
15. Cooksey JA, Knapp KK, Walton SM, et al. Challenges to the pharmacist profession from escalating pharmaceutical demand. Health Aff. 2002; 21:182-188.
16. Mott DA, Doucette DW, Gaither CA, et al. Pharmacist participation in the workforce: 1990, 2000, and 2004. J Am Pharm Assoc. 2006;46:322-330.
17. Kreling DH, Doucette DW, Mott DA, et al. Community pharmacists' work environments: evidence from the 2004 National Pharmacist Work-force Study. J Am Pharm Assoc. 2006;46:331-339.
18. Walton SM. The pharmacist shortage and medication errors: issues and evidence. J Med Syst. 2004;28:63-69.
19. Young D. Shortage of pharmacists may have contributed to patient's death. Am J Health Syst Pharm. 2002;59:2042, 2044-2045.
20. Bond CA, Raehl CL, Pitterle ME, et al. Health care professional starring, hospital characteristics, and hospital mortality rates. Pharmacotherapy. 1999;19:130-138.
21. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19:556-564.
22. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy. 2000;20:609-621.
23. Bond CA, Raehl CL, Franke T. Medication errors in United States hospitals. Pharmacotherapy, 2001;21:1023-1036.
24. Bond CA, Raehl CL, Franke T. Clinical pharmacist starring in United States hospitals. Pharmacotherapy. 2002;22:1489-1499.
25. LaPointe NM, Jollis JG. Medication errors in hospitalized cardiovascular patients. Arch Intern Med. 2003;163:1461-1466.
26. Bond CA, Raehl CL. Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, medicare charges, bleeding complications, and transfusions. Pharmacotherapy. 2004;24: 953-963.
27. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit [see comment], JAMA. 1999;282:267-270.
28. Erratum appears in JAMA. 2000; 283:1293.
29. Aiken LH, Clarke SP, Sloane DM, et al. Hospital nurse starring and patient mortality, nurse burnout, and job dissatisfaction [see comment]. JAMA. 2002;288: 1987-1993.
30. Needleman J, Buerhaus P, Mattke S, et al. Nurse-staffing levels and the quality of care in hospitals [see comment]. N Engl J Med. 2002;346: 1715-1722.
31. Coffman JM, Seago JA, Spetz J. Minimum nurse-to-patient ratios in acute care hospitals in California [see comment]. Health Aff. 2002;21: 53-64.
32. Glassman PA, Simon B, Belperio P, et al. Improving recognition of drag interactions: benefits and barriers to using automated drug alerts. Med Care. 2002;40:1161-1171.
33. Glassman PA, Belperio P, Simon B, et al. Exposure to automated drag alerts over time: effects on clinicians' knowledge and perceptions. Med Care. 2006;44:250-256.
34. Weideman RA, Bernstein IH, McKinney WP. Pharmacist recognition of potential drug interactions. Am J Health Syst Pharm. 1999;56:1524-1529.
35. Hazlet TK, Lee TA, Hansten PD, et al. Performance of community pharmacy drug interaction software [see comment]. J Am Pharm Assoc. 2001;41:200-204.
36. Abarca J, Colon LR, Wang VS, et al. Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies. J Manag Care Pharm. 2006;12:383-389.
37. Becker ML, Kallewaard M, Caspers PWJ, et al. Potential determinants of drug-drug interaction associated dispensing in community pharmacies. Drug Saf. 2005;28:371-378.
38. Peng CC, Glassman PA, Marks IR, et al. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population. J Manag Care Pharm. 2003;9:513-522.
39. Malone DC, Hutchins DS, Haupert H, et al. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm. 2005;62:1983-1991.
40. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289:1652-1658.
41. Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf. 1993;9:51-59.
42. Puckett WH Jr, Visconti JA. Epidemiological study of the clinical significance of drug-drug interactions in a private community hospital. Am J Hosp Pharm. 1971;28:247-253.
43. Hamilton R A, Briceland LL, Andritz MH. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population. Pharmacotherapy. 1998;18:1112-1120.
44. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting [see comment]. JAMA. 2003;289:1107-1116.
45. Ray WA, Murray KT, Meredith S, et al. Oral erythromycin and the risk of sudden death from cardiac causes [see comment]. W Engl J Med. 2004;351:1089-1096.
46. Flockhart DA, Drici MD, Kerbusch T, et al. Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. J Clin Psychopharmacol. 2000;20:317-324.
47. Edwards MB, Gronlund SD. Task interruption and its effects on memory. Memory. 1998;6:665-687.
48. Chisholm CD, Collison EK, Nelson DR, et al. Emergency department workplace interruptions: are emergency physicians "interrupt-driven" and "multitasking"? Acad Emerg Med. 2000;7:1239-1243.
49. NACDS. NACDS Foundation Chain Pharmacy Industry Profile. 2005 ed. Alexandria, VA: NACDS; 2006.